Longeveron Inc. is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs. Its lead investigational product, laromestrocel (Lomecel-B), is a proprietary allogeneic cellular therapy with pro-vascular, pro-regenerative, and anti-inflammatory mechanisms. The company is pursuing clinical development for four indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease, Pediatric Dilated Cardiomyopathy, and Aging-related Frailty, and manufactures its investigational products at its Miami cGMP facility.
expected 2026-12-23
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-17 | 2025-12-31 | 0001193125-26-110664 | EDGAR | 101K words |
| 2025-02-28 | 2024-12-31 | 0000950170-25-029968 | EDGAR | 103K words |
| 2024-02-27 | 2023-12-31 | 0001213900-24-017521 | EDGAR | 96K words |
| 2023-03-14 | 2022-12-31 | 0001213900-23-020006 | EDGAR | — |
| 2022-03-11 | 2021-12-31 | 0001213900-22-011894 | EDGAR | — |
| 2021-03-30 | 2020-12-31 | 0001213900-21-018716 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-12 | 2026-06-30 | 0001193125-26-346794 | EDGAR | 31K words |
| 2025-11-04 | 2025-09-30 | 0001193125-25-264604 | EDGAR | 27K words |
| 2025-08-13 | 2025-06-30 | 0000950170-25-107983 | EDGAR | 32K words |
| 2025-05-08 | 2025-03-31 | 0000950170-25-066889 | EDGAR | 27K words |
| 2024-11-12 | 2024-09-30 | 0000950170-24-125338 | EDGAR | 30K words |
| 2024-08-14 | 2024-06-30 | 0001213900-24-068987 | EDGAR | 29K words |
| 2024-05-14 | 2024-03-31 | 0001213900-24-042909 | EDGAR | 23K words |
| 2023-11-09 | 2023-09-30 | 0001213900-23-085194 | EDGAR | 26K words |
| 2023-08-11 | 2023-06-30 | 0001213900-23-065909 | EDGAR | 27K words |
| 2023-05-12 | 2023-03-31 | 0001213900-23-039003 | EDGAR | 23K words |
| 2022-11-14 | 2022-09-30 | 0001213900-22-072161 | EDGAR | — |
| 2022-08-12 | 2022-06-30 | 0001213900-22-047372 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-23 | 0001213900-26-102611 | EDGAR | 3K words |
| 2026-09-14 | 0001213900-26-099712 | EDGAR | 1K words |
| 2026-08-24 | 0001213900-26-093028 | EDGAR | 2K words |
| 2026-08-19 | 0001213900-26-091677 | EDGAR | 1K words |
| 2026-08-12 | 0001213900-26-088365 | EDGAR | 4K words |
| 2026-07-29 | 0001213900-26-082786 | EDGAR | 1K words |
| 2026-07-14 | 0001213900-26-078019 | EDGAR | 5K words |
| 2026-03-25 | 0001213900-26-034045 | EDGAR | 1K words |
| 2026-03-24 | 0001213900-26-033501 | EDGAR | 1K words |
| 2026-03-12 | 0001213900-26-026930 | EDGAR | 2K words |
147 total filings indexed. 119 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001721484 |
| Ticker | LGVN |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Headquarters | Miami, Florida |
| Website | https://www.longeveron.com |
| Listed | 2021-02-12 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/LGVN (~200 tokens, structured JSON with cryptographic provenance)